Carly Robinson focuses her practice on the unique needs of public and private life science company, including early stage corporate and commercial transactions as well as clinical trials and strategic partnerships for the research, development, and commercialization of novel products./

Download full bio 


  • Scorpion Therapeutics Enters Collaboration Agreement with AstraZeneca 

  • Immatics Enters Global Exclusive License Agreement With Bristol Myers Squibb 

  • Prothena Agrees to Sell ATTR Amyloidosis Program to Novo Nordisk 


  • William & Mary Law School
    JD, magna cum laude, Order of the Coif, 2019

  • University of Virginia
    BA, History
    high distinction, 2015

Admissions & Credentials


District of Columbia


  • Virginia Bar Association